Reply Re: Comparison of preferences between onabotulinumtoxina (botox) and incobotulinumtoxina (xeomin) in the treatment of benign essential blepharospasm"

Research output: Contribution to journal › Letter › peer-review

Fingerprint

Dive into the research topics of 'Reply Re: Comparison of preferences between onabotulinumtoxina (botox) and incobotulinumtoxina (xeomin) in the treatment of benign essential blepharospasm"'. Together they form a unique fingerprint.